90 related articles for article (PubMed ID: 9417581)
1. [Critical evaluation of a "therapeutic study"].
Praxis (Bern 1994); 1997 Oct; 86(41):1603-7. PubMed ID: 9417581
[No Abstract] [Full Text] [Related]
2. The benefits of insulin therapy following acute myocardial infarction revisited.
Soran H; Barzangy B; Younis N
QJM; 2006 Sep; 99(9):635-7. PubMed ID: 16921196
[No Abstract] [Full Text] [Related]
3. [1997 highlights in diabetology].
Spinas GA
Schweiz Med Wochenschr; 1997 Dec; 127(51-52):2119-21. PubMed ID: 9487570
[No Abstract] [Full Text] [Related]
4. [Are the guidelines correct? Should all patients with coronary heart disease or diabetes be treated with a statin?].
Pöss J; Böhm M; Laufs U
Med Klin (Munich); 2009 Jan; 104(1):74-8. PubMed ID: 19142597
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trials remain fundamental to clinical decision making in Type II diabetes mellitus: a comment to the debate on randomized controlled trials (For debate).
Richter B; Berger M
Diabetologia; 2000 Apr; 43(4):528-32. PubMed ID: 10819251
[No Abstract] [Full Text] [Related]
6. [Diabetes and myocardial infarction: intensive glucose control important according to international guidelines].
Norhammar A; Malmberg K; Mellbin L; Rydén L
Lakartidningen; 2006 Nov 22-28; 103(47):3734, 3737-8; discussion 3738-9. PubMed ID: 17212326
[No Abstract] [Full Text] [Related]
7. No evidence for a reduction of myocardial infarctions by acarbose.
van de Laar FA; Lucassen PL
Eur Heart J; 2004 Jul; 25(13):1179; author reply 1179-80. PubMed ID: 15231377
[No Abstract] [Full Text] [Related]
8. Glucose-lowering therapy after myocardial infarction: more questions than answers.
Radke PW; Schunkert H
Eur Heart J; 2008 Jan; 29(2):141-3. PubMed ID: 18199566
[TBL] [Abstract][Full Text] [Related]
9. [High blood glucose in diabetics a risk factor in acute myocardial infarction. Intensive insulin therapy--an interesting but not functioning idea].
Dellborg M; Svensson AM
Lakartidningen; 2006 Sep 13-19; 103(37):2624-5. PubMed ID: 17022181
[No Abstract] [Full Text] [Related]
10. Intensive glucose lowering treatment in type 2 diabetes.
Preiss D; Ray KK
BMJ; 2011 Jul; 343():d4243. PubMed ID: 21791496
[No Abstract] [Full Text] [Related]
11. Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen. The TRACE Study Group.
Gustafsson I; Hildebrandt P; Seibaek M; Melchior T; Torp-Pedersen C; Køber L; Kaiser-Nielsen P
Eur Heart J; 2000 Dec; 21(23):1937-43. PubMed ID: 11071799
[TBL] [Abstract][Full Text] [Related]
12. Primary percutaneous coronary intervention compared with fibrinolysis for myocardial infarction in diabetes mellitus: results from the Primary Coronary Angioplasty vs Thrombolysis-2 trial.
Timmer JR; Ottervanger JP; de Boer MJ; Boersma E; Grines CL; Westerhout CM; Simes RJ; Granger CB; Zijlstra F;
Arch Intern Med; 2007 Jul; 167(13):1353-9. PubMed ID: 17620527
[TBL] [Abstract][Full Text] [Related]
13. Intensive insulin treatment of diabetic patients with myocardial infarction is highly cost-effective.
Hildebrandt P
Eur Heart J; 2000 May; 21(9):700-2. PubMed ID: 10739721
[No Abstract] [Full Text] [Related]
14. Outcomes of diabetic patients following acute myocardial infarction: a review of the major thrombolytic trials.
Jelesoff NE; Feinglos M; Granger CB; Califf RM
J Cardiovasc Risk; 1997 Apr; 4(2):100-11. PubMed ID: 9304491
[No Abstract] [Full Text] [Related]
15. Therapeutic hypothermia for acute myocardial infarction: past, present, and future.
Parham W; Edelstein K; Unger B; Mooney M
Crit Care Med; 2009 Jul; 37(7 Suppl):S234-7. PubMed ID: 19535952
[TBL] [Abstract][Full Text] [Related]
16. Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38.
Wiviott SD; Braunwald E; Angiolillo DJ; Meisel S; Dalby AJ; Verheugt FW; Goodman SG; Corbalan R; Purdy DA; Murphy SA; McCabe CH; Antman EM;
Circulation; 2008 Oct; 118(16):1626-36. PubMed ID: 18757948
[TBL] [Abstract][Full Text] [Related]
17. [Insulin in the diabetic heart patient, only the glycemic results count].
Fredenrich A
Soins; 2006 Mar; (703 Suppl 1):1S18-20. PubMed ID: 16604812
[No Abstract] [Full Text] [Related]
18. Glitazones in type 2 diabetes: an update.
Drug Ther Bull; 2008 Apr; 46(4):25-9. PubMed ID: 18403615
[TBL] [Abstract][Full Text] [Related]
19. Thrombolytic treatment in diabetic patients with acute myocardial infarction: lower rates of use than in non-diabetic patients are explained by differences in presenting ECGs.
Kvan E; Reikvam A;
Heart; 2004 Nov; 90(11):1346-7. PubMed ID: 15486144
[No Abstract] [Full Text] [Related]
20. [Does targeted therapy of type 2 diabetes prevent cardiovascular incidents?].
Leschke M
Med Klin (Munich); 2003 Oct; 98 Suppl 1():12-6. PubMed ID: 14694836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
